Demand for non-surgical cosmetic treatments continues to increase dramatically as a new generation of facial fillers and liquid facelift techniques promises better results in the battle against aging, while avoiding the risks inherent in facial plastic surgery. While hyaluronic acid fillers have earned an excellent track record for safety and effectiveness in treating fine lines and wrinkles around the eyes, nose and mouth, there are exciting new volumizers in the pipeline that are able to accomplish large-scale facial sculpturing without surgery.
Juvéderm™ VOLUMA™, a long-lasting hyaluronic acid volumizer that has been widely available in Europe over the last 2 years, is currently undergoing FDA studies in the United States. It is hoped that this product will be available in 2011. VOLUMA™ works to restore fuller, softer, and more youthful contours to the face by replacing lost volume in the cheeks, chin and cheekbones. VOLUMA™ provides smooth, natural-looking results that have been shown, in European studies, to last up to 18 months.
Belotero® is another hyaluronic acid material that is expected to be FDA approved in 2010.
The proliferation of facial filler and volumizer products available today is both a blessing and a challenge for people seeking non-surgical facial rejuvenation. With such a wide range of treatment choices available, it can be difficult for patients to know how to choose the treatment that’s best for them. A qualified, experienced physician can help you navigate the facial filler landscape and choose a treatment best suited to achieve your specific goals.
The 34th Annual Hawaii Dermatology Seminar, sponsored by the Skin Disease Education Foundation (SDEF), brings together the world’s leading dermatologists to discuss current challenges and future directions in the field of dermatology. For further information about the SDEF, visit www.sdefderm.com.